Table 2.
The relation of NPTX2 to cognitive function and cognitive decline in DLB patients.
| 95% Confidence | ||||
|---|---|---|---|---|
| Cognitive function | β | Sig. | Lower | Upper |
| Global median n = 39 | 0.2642 | 0.045 | 0.006 | 0.522 |
| Memory n = 39 | 0.1931 | 0.595 | −0.538 | 0.925 |
| Attention n = 39 | 1.0938 | 0.019 | 0.194 | 1.994 |
| Executive =39 | −0.0957 | 0.755 | −0.714 | 0.523 |
| Language n = 39 | 0.2681 | 0.063 | −0.015 | 0.552 |
| Visual n = 30 | −0.7258 | 0.197 | −1.853 | 0.401 |
| MMSE n = 40 | 0.7791 | 0.406 | −1.102 | 2.660 |
| Cognitive decline | ||||
| Global median n = 32 | 0.0006 | 0.837 | −0.005 | 0.007 |
| Memory n = 32 | 0.0019 | 0.831 | −0.016 | 0.020 |
| Attention n = 32 | 0.0056 | 0.753 | −0.030 | 0.041 |
| Executive n = 32 | 0.0001 | 0.985 | −0.014 | 0.014 |
| Language n = 32 | 0.0031 | 0.393 | −0.004 | 0.010 |
| Visual n = 28 | 0.0436 | 0.002 | 0.016 | 0.071 |
| MMSE n = 33 | 0.0014 | 0.950 | −0.041 | 0.044 |
For each domain, the beta significance level, and 95% confidence intervals of a model relating NPTX2 to that specific cognitive domain are given. The upper set depicts those values for linear models with cognitive function. The lower set shows the values for a linear mixed model for cognitive decline for each domain. Significant values are indicated by bold underline italic fonts.